Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2012
07/03/2012US8211666 Sperm-specific cation channel, CATSPER1, and uses therefor
07/03/2012US8211661 Method for identifying individuals having a pervasive development disorder amenable to digestive enzyme therapy
07/03/2012US8211658 Complex of a chaperone with β-amyloid and methods employing this complex
07/03/2012US8211476 Compositions against rotavirus infection and processes for producing the same
07/03/2012US8211467 Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
07/03/2012US8211447 Recombinant P. falciparum merozoite protein-142 vaccine
07/03/2012US8211439 Albumin fusion proteins comprising insulin polypeptides
07/03/2012US8211432 Treatment of Staphylococcus aureus infections utilizing antibodies that bind to fibronectin binding proteins
07/03/2012US8211428 Protease screening methods and proteases identified thereby
07/03/2012US8211427 EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
07/03/2012US8211426 ACE2 activation for treatment of heart, lung and kidney disease and hypertension
07/03/2012US8211422 Comprising a first gene segment encoding a single-chain Fv domain (scFv) of a specific antibody and a second gene segment encoding partially or entirely the transmembrane and cytoplasmic domains; gene therapy; antitumor agents
07/03/2012US8211421 Mutant having uracil phosphoribosyl transferase activity
07/03/2012CA2671904C Intermediate duration neuromuscular blocking agents and antagonists thereof
07/03/2012CA2640956C B7rp-1 polypeptides
07/03/2012CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2
07/03/2012CA2519789C Aplidine for multiple myeloma treatment
07/03/2012CA2505639C System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled toa single-needle or multi-needle intradermal (id) delivery device
07/03/2012CA2463631C Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
07/03/2012CA2445577C Subcellular targeting of therapeutic proteins
07/03/2012CA2441595C Proteins producing an altered immunogenic response and methods of making and using the same
07/03/2012CA2406132C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2350227C Novel serine protease bssp5
07/03/2012CA2315294C Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
07/03/2012CA2305269C Treatment of neoplasms with viruses
07/03/2012CA2296737C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2296711C Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
07/03/2012CA2196555C Vr-2332 viral nucleotide sequence and methods of use
07/02/2012CA2806314A1 Method for purifying active polypeptides or immunoconjugates
06/2012
06/28/2012WO2012088446A1 Superagonists and antagonists of interleukin-2
06/28/2012WO2012088434A2 Compositions relating to a phosphoprotein and methods of use
06/28/2012WO2012088425A2 Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
06/28/2012WO2012088397A2 Cyclic crf antagonist peptides
06/28/2012WO2012088388A2 Treating multiple myeloma
06/28/2012WO2012088379A2 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
06/28/2012WO2012088220A2 Expression of thrombin variants
06/28/2012WO2012088157A2 Glp-1 receptor agonists for islet cell transplantation
06/28/2012WO2012088116A2 Glucagon analogs exhibiting gip receptor activity
06/28/2012WO2012088006A1 Fibronectin based scaffold domain proteins that bind il-23
06/28/2012WO2012087943A2 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
06/28/2012WO2012087925A1 Factor h binding peptides and uses thereof
06/28/2012WO2012087913A2 Peptide reagents and methods for detection of colon dysplasia
06/28/2012WO2012087742A2 Methods and compositions suitable for managing blood glucose in animals
06/28/2012WO2012087726A1 Methods and compositions for the treatment of "burning feet syndrome"
06/28/2012WO2012087234A1 A composition comprising at least to compounds which induces indolamine 2,3-dioxygenase (ido), for the treatment of an autoimmune disorder or suffering from immune rejection of organs
06/28/2012WO2012087181A1 Pharmaceutical composition for treating viral diseases
06/28/2012WO2012087180A1 Method for treating acute cerebral and spinal blood flow disorders of an ischaemic or haemorrhagic nature
06/28/2012WO2012087160A2 Anti-inflammatory proteins and methods of preparation and use thereof
06/28/2012WO2012087017A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same
06/28/2012WO2012086474A1 Therapeutic agent for central nervous system diseases
06/28/2012WO2012086428A1 Medicinal composition comprising calmodulin-like skin protein as active ingredient
06/28/2012WO2012085933A1 Pharmaceutical compositions of tenecteplase
06/28/2012WO2012085910A1 Viral inactivated platelet extract, use and preparation thereof
06/28/2012WO2012085793A1 Use of pegylated recombinant human arginase for treatment of leukemia
06/28/2012WO2012085622A1 Therapeutic strategies to treat cns pathology in mucopolysaccharidoses
06/28/2012WO2012085221A1 Derivatives of glyco-cf2-serine and glyco-cf2-threonine
06/28/2012WO2012085178A1 Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
06/28/2012WO2012085165A1 Tear substitutes
06/28/2012WO2012085096A1 Peptides for treating cancer
06/28/2012WO2012085076A1 uPAR-ANTAGONISTS AND USES THEREOF
06/28/2012WO2012084459A1 Prevention and therapy methods for preterm deliveries and births
06/28/2012WO2012083861A1 Method for preparing atosiban acetate
06/28/2012WO2012083436A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
06/28/2012WO2012083396A1 Method for increasing embryo implantation rate in mother's uterus in mammals, use of an effective amount of beta - galactoside - binding lectin or derivatives thereof, beta - galactoside - binding lectin or derivatives and product.
06/28/2012WO2012083385A1 Serine protease inhibitors
06/28/2012WO2012083382A1 Conjugates of acyl homoserine lactone and catalase a from pseudomonas aeruginosa
06/28/2012WO2012067427A9 Pharmaceutical composition containing lk8 protein as an active ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration
06/28/2012WO2012058616A3 Engineered kinetochores and uses thereof
06/28/2012WO2012057525A3 Liquid formulations of long acting interferon alpha conjugate
06/28/2012WO2012049324A3 New emd formulation comprising pga
06/28/2012WO2012045751A3 Multivalent synthetic compounds as antibiotic treatment
06/28/2012WO2012045750A3 Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
06/28/2012WO2012041981A3 Use of growth hormone to enhance the immune response in immunosuppressed patients
06/28/2012WO2012040444A3 Treatment of patients with incipient alzheimer's disease
06/28/2012WO2012039578A3 Composition for preventing and treating amyloid diseases, comprising cyclophilin b
06/28/2012WO2012037397A3 Step-derived peptide for brain injury treatment
06/28/2012WO2012036437A3 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease
06/28/2012WO2012036433A3 Treatment of neurodegenerative diseases by targeting mirna
06/28/2012WO2012036412A9 Peptide having a vascularization-suppressing activity and a use therefor
06/28/2012WO2012032068A3 Compounds and methods
06/28/2012WO2012022467A3 Novel benzoquinone derivatives and use thereof as modulators of mitochondrial function
06/28/2012WO2012013331A3 Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases
06/28/2012WO2012010946A3 Bnip3 isoforms and methods of use
06/28/2012WO2011162558A3 Recombinant vector for suppressing proliferation of human papillomavirus cell including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papillomavirus
06/28/2012WO2011150144A3 Aqueous formulations for coating microneedle arrays
06/28/2012WO2011133685A9 Nanoparticle targeting to ischemia for imaging and therapy
06/28/2012WO2011130716A3 A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers
06/28/2012WO2010039223A3 T-cell immunogens derived from anti-viral proteins and methods of using same
06/28/2012US20120167240 Compositions and Methods for Modulating PGC-1Alpha to Treat Neurological Diseases and Disorders
06/28/2012US20120165939 Nonwoven tissue scaffold
06/28/2012US20120165731 Compositions and methods for treating joints
06/28/2012US20120165566 Processes for intermediates for macrocyclic compounds
06/28/2012US20120165398 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120165276 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
06/28/2012US20120165275 Nitrogen-Based Linkers for Attaching Modifying Groups to Polypeptides and Other Macromolecules
06/28/2012US20120165274 Three-dimensional structures of tall-1 and its cognate receptors and modified proteins and methods related thereto
06/28/2012US20120165273 Eye drops
06/28/2012US20120165272 Tear Substitutes
06/28/2012US20120165271 Methods of treating retinitis pigmentosa
1 ... 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 ... 3163